AccuStem Sciences, Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported net loss was USD 0.526602 million compared to USD 0.833341 million a year ago. Basic loss per share from continuing operations was USD 0.05 compared to USD 0.07 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4011 USD | +2.56% | +14.24% | -35.90% |
1st Jan change | Capi. | |
---|---|---|
-35.90% | 4.55M | |
-5.81% | 180B | |
-1.63% | 106B | |
-4.14% | 67.55B | |
-6.56% | 46.11B | |
+13.22% | 45.79B | |
+6.13% | 41.61B | |
+19.93% | 31.07B | |
+13.61% | 24.77B | |
-5.36% | 24.27B |
- Stock Market
- Equities
- ACUT Stock
- News AccuStem Sciences, Inc.
- AccuStem Sciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024